In short. How bullous pemphigoid differs from pemphigus in age, course and treatment, and where the rarer blistering diseases fit.
Key points
- Pemphigus splits high, heals poorly, and is often severe in the mouth.
- Bullous pemphigoid splits low, forms tense blisters, spares the mouth and itches relentlessly.
- That is why one specialty treats them very differently.
Bullous pemphigoid is the commonest autoimmune blistering disease, and it behaves very differently from pemphigus. Its antibodies target proteins at the junction between the epidermis and the dermis, so the split forms beneath the epidermis rather than within it. The blister roof is therefore the full thickness of the epidermis: tough rather than fragile. The blisters are tense, dome-shaped and slow to rupture. That single anatomical difference explains much of what follows.
Who it affects and how it presents
Bullous pemphigoid usually appears after the age of seventy and is uncommon below sixty. It often begins with an intensely itchy, hive-like rash that can persist for weeks before any blister appears, which is why it is sometimes treated for months as eczema or as scabies. Blisters then develop on the trunk, limbs and skin folds. Mucous membrane involvement is mild or absent, in contrast to pemphigus. The itch can be severe enough to disturb sleep and to dominate the illness.
Why age matters
Because most patients are elderly, the disease interacts with everything else they carry: frailty, other medical conditions, multiple medicines, and cognitive impairment. Treatment decisions weigh the burden of immunosuppression against the burden of the disease itself, and the two are not always easily balanced. Some medicines have been reported to set the condition off, so a medication review is part of the assessment.
Other blistering diseases
Pemphigoid gestationis appears during pregnancy or shortly after delivery and needs joint care with obstetric services. Linear IgA disease produces a ring-like blistering pattern and occurs in both children and adults. Epidermolysis bullosa acquisita is a chronic disease in which blisters heal with scarring and milia, and it can be stubborn. Dermatitis herpetiformis is intensely itchy and is tied to gluten sensitivity, so it prompts investigation for coeliac disease. Each is confirmed by the pattern of antibody deposition seen on direct immunofluorescence.
Treatment and how it differs
Treatment classes overlap with pemphigus, but the emphasis differs. Potent topical corticosteroids applied to affected areas are effective in limited disease and avoid systemic exposure, which matters greatly in older patients. When systemic treatment is needed, corticosteroids are used at the lowest useful exposure and steroid-sparing agents are added early. Biologics and intravenous immunoglobulin are used in selected cases. Because the disease tends to run a more limited course than pemphigus, treatment is often tapered sooner, but relapse is still common and the taper is planned rather than improvised.
Monitoring and support
Blood counts, blood sugar, blood pressure, bone protection and infection surveillance all apply. So does skin care: dressing eroded areas, controlling itch, and treating secondary infection. In older patients, nursing and occupational support often matters as much as the prescription itself.
The practical difference
Pemphigus splits high, heals poorly, and is often severe in the mouth. Bullous pemphigoid splits low, forms tense blisters, spares the mouth and itches relentlessly. That is why one specialty treats them very differently.
Seek care urgently if
- A widespread itchy rash is beginning to blister, particularly in an older person.
- Blisters cover a large area, or the skin beneath them looks infected, hot or painful.
- Eating, drinking or swallowing becomes difficult because of sores in the mouth.
Frequently asked questions
How does bullous pemphigoid differ from pemphigus?
The split forms beneath the epidermis rather than within it, so the blister roof is the full thickness of the epidermis: tough rather than fragile, and the blisters are tense and slow to rupture. Mucous membrane involvement is mild or absent, unlike pemphigus, but the itch can be severe.
Why does age change how bullous pemphigoid is treated?
Most patients are elderly, so the disease interacts with frailty, other medical conditions, multiple medicines and cognitive impairment. Treatment decisions weigh the burden of immunosuppression against the burden of the disease itself. Potent topical corticosteroids treat limited disease while avoiding systemic exposure, which matters greatly in older patients.
Can a rash be bullous pemphigoid before any blister appears?
Yes. It often begins with an intensely itchy, hive-like rash that can persist for weeks before any blister appears, which is why it is sometimes treated for months as eczema or as scabies. Blisters then develop on the trunk, limbs and skin folds.
Risks & Limitations
- These are chronic conditions that are managed rather than cured, and flares are expected along the way.
- Immunosuppressive treatment raises the risk of infection and needs regular blood monitoring.
- Long-term systemic corticosteroids carry real side effects, including bone, metabolic and eye complications.
- Steroid-sparing agents and biologics have their own risks, including blood count, liver and kidney effects.
- Treatment is usually long term, and relapse is common when it is reduced or stopped.
- No treatment works for everyone, response cannot be predicted, and nothing here is guaranteed.
- Some scarring, pigment change and hair loss may be permanent even with good control.
When to Seek Care
- Widespread blistering, or raw eroded skin that is spreading — seek urgent care.
- Blistering or erosions in the mouth or throat that make eating or drinking difficult — seek urgent care.
- Fever with a rash, especially while on immunosuppressive treatment.
- Sudden severe skin pain or peeling of the skin — seek emergency care immediately.
- New breathlessness or chest pain, which may indicate involvement beyond the skin — seek emergency care.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- International Pemphigus & Pemphigoid Foundation — patient and clinical resources
- Cochrane Library — systematic reviews in dermatology
- Chinese Medical Association, Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.